|
|
|
|
|
|
Vascular Biogen. Ord (VBLT)
|
|
5.10 +0.05 (+0.99%)
|
8/23/2017 4:00pm
|
|
Open:
|
5.10
|
Pre. Close:
|
5.05
|
|
High:
|
5.10
|
Low:
|
5.00
|
|
Volume:
|
30,275
|
Market Cap:
|
137.75M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
5.22 - 5.39
|
5.39 - 5.54
|
|
Low:
|
4.76 - 4.84
|
4.84 - 4.9
|
|
Close:
|
4.92 - 5.16
|
5.16 - 5.35
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-23 4:55:30 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 6.13 One year: 7.16
|
|
Support:
|
Support1: 4.42 Support2: 3.90
|
|
Resistance:
|
Resistance1:
5.25 Resistance2: 6.13
|
|
Pivot:
|
4.59 
|
|
Moving Averages:
|
MA(5): 5.08 MA(20): 4.48
MA(100): 5.03  MA(250): 5.08
|
|
MACD:
|
MACD(12,26):
0.19 Signal(12,26,9): 0.08
|
|
%K %D:
|
%K(14,3): 85.19 %D(3): 86.24
|
|
RSI:
|
RSI(14): 70.47
|
|
52-Week:
|
High: 6.70
Low: 3.90 Change(%): 20.3
|
|
Average Vol(K):
|
3-Month: 7791
10-Days 880
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.VBLT has closed below upper band by 21.1%. Bollinger Bands are 90.7% wider than normal. The large width of the bands suggest high volatility as compared to VBLT's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Thu, 02 Oct 2014 20:04:30 GMT
5.05
Mon, 15 May 2017 15:45:00 GMT
Vascular Biogenics' (VBLT) CEO Dror Harats on Q1 2017 Results - Earnings Call ...
Mon, 15 Aug 2016 16:41:14 GMT
Vascular Biogenics' (VBLT) CEO Dror Harats on Q2 2016 Results - Earnings Call ...
Wed, 16 Aug 2017 18:43:00 GMT
Strength Seen in Vascular Biogenics (VBLT): Stock Jumps 5.3%
Tue, 22 Aug 2017 11:37:13 GMT
Trading Options During Earnings in Vascular Biogenics Ltd.
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
